Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals
Neutrophils (PMN) preincubated with recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) for 2 h and then stimulated with the chemotactic factors, C5a or FMLP, produce substantial amounts of the lipoxygenase products 5-Hete, LTB4, and omega-oxidised LTB4 metabolites (4.36 +/...
Gespeichert in:
Veröffentlicht in: | The Journal of experimental medicine 1988-04, Vol.167 (4), p.1281-1295 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1295 |
---|---|
container_issue | 4 |
container_start_page | 1281 |
container_title | The Journal of experimental medicine |
container_volume | 167 |
creator | DAHINDEN, C. A ZINGG, J MALY, F. E DE WECK, A. L |
description | Neutrophils (PMN) preincubated with recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) for 2 h and then stimulated with the chemotactic factors, C5a or FMLP, produce substantial amounts of the lipoxygenase products 5-Hete, LTB4, and omega-oxidised LTB4 metabolites (4.36 +/- 0.95 (SEM) pM (n = 21) LTB4 and LTB4 metabolites/10(6) PMN). No lipoxygenase metabolites are detected by HPLC and RIA if purified PMN are stimulated by either GM-CSF or chemotactic factors in the absence of exogenous arachidonate. The priming effect of GM-CSF upon chemotactic factor induced generation of lipid mediators is a relatively slow process, clearly evident after 1 h and optimal after 2 h. Leukotriene generation is measurable with 0.8 U GM-CSF/10(6) PMN and is maximal with 80 U (10(-11)-10(-9) M). Upon activation of primed PMN with chemotactic factors, leukotriene synthesis is induced very rapidly. Already 2.5 min after activation the major lipoxygenase metabolites present are 20-OH LTB4 and 20-COOH LTB4. Our study shows that the synthesis of lipoxygenase metabolites from endogeneous AA can be initiated in PMN through receptor mediated processes by the appropriately timed combination of biological soluble inflammatory mediator peptides. Furthermore, these results indicate that GM-CSF not only enhances effector cell functions but can qualitatively change the mediator profile formed after activation with a second triggering signal. Such a mechanism might be important in amplifying inflammatory responses. Alternatively, lipid mediators formed might also have an intracellular or autocoid role and be responsible for the enhancement of other PMN functions like oxygen radical release. |
doi_str_mv | 10.1084/jem.167.4.1281 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2188926</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14928175</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-4b36303efe48aa74e7c49ab3081f4e177bfbc62d282a367924d08bfcbc64c2d23</originalsourceid><addsrcrecordid>eNpVUUtv1DAQjhCoLIUrNyQfELekfiV2LkjVihakRXCAs-U4TuLi2IvtFO3_44fVoWEFJ4_me8x4vqJ4jWCFIKdXd3quUMMqWiHM0ZNih2oKy7Ym_GmxgxDjEkHInhcvYryDEFFaNxfFBeaE1HWzK34f9PLDp2C00-AYfL-oZLwDxoFpmaUDTi8p-ONkbMy4mXUPuhMIWvm5M066tPHGIN1ivTolfTVLtUrkqIHy1rtTGZOZFyuTcSMYpEo-AOl68LedTX-ZNIE0rYr5aPWss_NaerdW-_r6j-Dm8-ErkBHEPH_Vm9FJG18Wz4b86Ffbe1l8v_nwbf-xPHy5_bS_PpQqfzuVtCMNgUQPmnIpGdVM0VZ2BHI0UI0Y64ZONbjHHEvSsBbTHvJuULlJVW6Ty-L9o-9x6fIhVN4sSCvWs8hwEl4a8T_izCRGfy8w4rzFTTZ4txkE_3PRMYnZRKWtlU77JQpE2xwiqzOxeiTmQ8YY9HAegqBYcxc5d5FzF1SsuWfBm39XO9O3oDP-dsNlVNIOOS1l4pnGICGMUvIA1y29sQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14928175</pqid></control><display><type>article</type><title>Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>DAHINDEN, C. A ; ZINGG, J ; MALY, F. E ; DE WECK, A. L</creator><creatorcontrib>DAHINDEN, C. A ; ZINGG, J ; MALY, F. E ; DE WECK, A. L</creatorcontrib><description>Neutrophils (PMN) preincubated with recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) for 2 h and then stimulated with the chemotactic factors, C5a or FMLP, produce substantial amounts of the lipoxygenase products 5-Hete, LTB4, and omega-oxidised LTB4 metabolites (4.36 +/- 0.95 (SEM) pM (n = 21) LTB4 and LTB4 metabolites/10(6) PMN). No lipoxygenase metabolites are detected by HPLC and RIA if purified PMN are stimulated by either GM-CSF or chemotactic factors in the absence of exogenous arachidonate. The priming effect of GM-CSF upon chemotactic factor induced generation of lipid mediators is a relatively slow process, clearly evident after 1 h and optimal after 2 h. Leukotriene generation is measurable with 0.8 U GM-CSF/10(6) PMN and is maximal with 80 U (10(-11)-10(-9) M). Upon activation of primed PMN with chemotactic factors, leukotriene synthesis is induced very rapidly. Already 2.5 min after activation the major lipoxygenase metabolites present are 20-OH LTB4 and 20-COOH LTB4. Our study shows that the synthesis of lipoxygenase metabolites from endogeneous AA can be initiated in PMN through receptor mediated processes by the appropriately timed combination of biological soluble inflammatory mediator peptides. Furthermore, these results indicate that GM-CSF not only enhances effector cell functions but can qualitatively change the mediator profile formed after activation with a second triggering signal. Such a mechanism might be important in amplifying inflammatory responses. Alternatively, lipid mediators formed might also have an intracellular or autocoid role and be responsible for the enhancement of other PMN functions like oxygen radical release.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.167.4.1281</identifier><identifier>PMID: 2833556</identifier><identifier>CODEN: JEMEAV</identifier><language>eng</language><publisher>New York, NY: Rockefeller University Press</publisher><subject>Adult ; Arachidonate 5-Lipoxygenase - metabolism ; Biological and medical sciences ; Colony-Stimulating Factors - pharmacology ; Complement C5 - pharmacology ; Complement C5a ; Drug Synergism ; Fundamental and applied biological sciences. Psychology ; Granulocytes ; Humans ; Hydroxyeicosatetraenoic Acids - biosynthesis ; Inflammation ; Leukotriene B4 - biosynthesis ; Macrophages ; Molecular and cellular biology ; N-Formylmethionine Leucyl-Phenylalanine - pharmacology ; Neutrophils - drug effects ; Neutrophils - metabolism ; Recombinant Proteins - pharmacology</subject><ispartof>The Journal of experimental medicine, 1988-04, Vol.167 (4), p.1281-1295</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-4b36303efe48aa74e7c49ab3081f4e177bfbc62d282a367924d08bfcbc64c2d23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7033744$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2833556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DAHINDEN, C. A</creatorcontrib><creatorcontrib>ZINGG, J</creatorcontrib><creatorcontrib>MALY, F. E</creatorcontrib><creatorcontrib>DE WECK, A. L</creatorcontrib><title>Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Neutrophils (PMN) preincubated with recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) for 2 h and then stimulated with the chemotactic factors, C5a or FMLP, produce substantial amounts of the lipoxygenase products 5-Hete, LTB4, and omega-oxidised LTB4 metabolites (4.36 +/- 0.95 (SEM) pM (n = 21) LTB4 and LTB4 metabolites/10(6) PMN). No lipoxygenase metabolites are detected by HPLC and RIA if purified PMN are stimulated by either GM-CSF or chemotactic factors in the absence of exogenous arachidonate. The priming effect of GM-CSF upon chemotactic factor induced generation of lipid mediators is a relatively slow process, clearly evident after 1 h and optimal after 2 h. Leukotriene generation is measurable with 0.8 U GM-CSF/10(6) PMN and is maximal with 80 U (10(-11)-10(-9) M). Upon activation of primed PMN with chemotactic factors, leukotriene synthesis is induced very rapidly. Already 2.5 min after activation the major lipoxygenase metabolites present are 20-OH LTB4 and 20-COOH LTB4. Our study shows that the synthesis of lipoxygenase metabolites from endogeneous AA can be initiated in PMN through receptor mediated processes by the appropriately timed combination of biological soluble inflammatory mediator peptides. Furthermore, these results indicate that GM-CSF not only enhances effector cell functions but can qualitatively change the mediator profile formed after activation with a second triggering signal. Such a mechanism might be important in amplifying inflammatory responses. Alternatively, lipid mediators formed might also have an intracellular or autocoid role and be responsible for the enhancement of other PMN functions like oxygen radical release.</description><subject>Adult</subject><subject>Arachidonate 5-Lipoxygenase - metabolism</subject><subject>Biological and medical sciences</subject><subject>Colony-Stimulating Factors - pharmacology</subject><subject>Complement C5 - pharmacology</subject><subject>Complement C5a</subject><subject>Drug Synergism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Granulocytes</subject><subject>Humans</subject><subject>Hydroxyeicosatetraenoic Acids - biosynthesis</subject><subject>Inflammation</subject><subject>Leukotriene B4 - biosynthesis</subject><subject>Macrophages</subject><subject>Molecular and cellular biology</subject><subject>N-Formylmethionine Leucyl-Phenylalanine - pharmacology</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - metabolism</subject><subject>Recombinant Proteins - pharmacology</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUUtv1DAQjhCoLIUrNyQfELekfiV2LkjVihakRXCAs-U4TuLi2IvtFO3_44fVoWEFJ4_me8x4vqJ4jWCFIKdXd3quUMMqWiHM0ZNih2oKy7Ym_GmxgxDjEkHInhcvYryDEFFaNxfFBeaE1HWzK34f9PLDp2C00-AYfL-oZLwDxoFpmaUDTi8p-ONkbMy4mXUPuhMIWvm5M066tPHGIN1ivTolfTVLtUrkqIHy1rtTGZOZFyuTcSMYpEo-AOl68LedTX-ZNIE0rYr5aPWss_NaerdW-_r6j-Dm8-ErkBHEPH_Vm9FJG18Wz4b86Ffbe1l8v_nwbf-xPHy5_bS_PpQqfzuVtCMNgUQPmnIpGdVM0VZ2BHI0UI0Y64ZONbjHHEvSsBbTHvJuULlJVW6Ty-L9o-9x6fIhVN4sSCvWs8hwEl4a8T_izCRGfy8w4rzFTTZ4txkE_3PRMYnZRKWtlU77JQpE2xwiqzOxeiTmQ8YY9HAegqBYcxc5d5FzF1SsuWfBm39XO9O3oDP-dsNlVNIOOS1l4pnGICGMUvIA1y29sQ</recordid><startdate>19880401</startdate><enddate>19880401</enddate><creator>DAHINDEN, C. A</creator><creator>ZINGG, J</creator><creator>MALY, F. E</creator><creator>DE WECK, A. L</creator><general>Rockefeller University Press</general><general>The Rockefeller University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>19880401</creationdate><title>Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals</title><author>DAHINDEN, C. A ; ZINGG, J ; MALY, F. E ; DE WECK, A. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-4b36303efe48aa74e7c49ab3081f4e177bfbc62d282a367924d08bfcbc64c2d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Arachidonate 5-Lipoxygenase - metabolism</topic><topic>Biological and medical sciences</topic><topic>Colony-Stimulating Factors - pharmacology</topic><topic>Complement C5 - pharmacology</topic><topic>Complement C5a</topic><topic>Drug Synergism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Granulocytes</topic><topic>Humans</topic><topic>Hydroxyeicosatetraenoic Acids - biosynthesis</topic><topic>Inflammation</topic><topic>Leukotriene B4 - biosynthesis</topic><topic>Macrophages</topic><topic>Molecular and cellular biology</topic><topic>N-Formylmethionine Leucyl-Phenylalanine - pharmacology</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - metabolism</topic><topic>Recombinant Proteins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAHINDEN, C. A</creatorcontrib><creatorcontrib>ZINGG, J</creatorcontrib><creatorcontrib>MALY, F. E</creatorcontrib><creatorcontrib>DE WECK, A. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAHINDEN, C. A</au><au>ZINGG, J</au><au>MALY, F. E</au><au>DE WECK, A. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>1988-04-01</date><risdate>1988</risdate><volume>167</volume><issue>4</issue><spage>1281</spage><epage>1295</epage><pages>1281-1295</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><coden>JEMEAV</coden><abstract>Neutrophils (PMN) preincubated with recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) for 2 h and then stimulated with the chemotactic factors, C5a or FMLP, produce substantial amounts of the lipoxygenase products 5-Hete, LTB4, and omega-oxidised LTB4 metabolites (4.36 +/- 0.95 (SEM) pM (n = 21) LTB4 and LTB4 metabolites/10(6) PMN). No lipoxygenase metabolites are detected by HPLC and RIA if purified PMN are stimulated by either GM-CSF or chemotactic factors in the absence of exogenous arachidonate. The priming effect of GM-CSF upon chemotactic factor induced generation of lipid mediators is a relatively slow process, clearly evident after 1 h and optimal after 2 h. Leukotriene generation is measurable with 0.8 U GM-CSF/10(6) PMN and is maximal with 80 U (10(-11)-10(-9) M). Upon activation of primed PMN with chemotactic factors, leukotriene synthesis is induced very rapidly. Already 2.5 min after activation the major lipoxygenase metabolites present are 20-OH LTB4 and 20-COOH LTB4. Our study shows that the synthesis of lipoxygenase metabolites from endogeneous AA can be initiated in PMN through receptor mediated processes by the appropriately timed combination of biological soluble inflammatory mediator peptides. Furthermore, these results indicate that GM-CSF not only enhances effector cell functions but can qualitatively change the mediator profile formed after activation with a second triggering signal. Such a mechanism might be important in amplifying inflammatory responses. Alternatively, lipid mediators formed might also have an intracellular or autocoid role and be responsible for the enhancement of other PMN functions like oxygen radical release.</abstract><cop>New York, NY</cop><pub>Rockefeller University Press</pub><pmid>2833556</pmid><doi>10.1084/jem.167.4.1281</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1007 |
ispartof | The Journal of experimental medicine, 1988-04, Vol.167 (4), p.1281-1295 |
issn | 0022-1007 1540-9538 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2188926 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Adult Arachidonate 5-Lipoxygenase - metabolism Biological and medical sciences Colony-Stimulating Factors - pharmacology Complement C5 - pharmacology Complement C5a Drug Synergism Fundamental and applied biological sciences. Psychology Granulocytes Humans Hydroxyeicosatetraenoic Acids - biosynthesis Inflammation Leukotriene B4 - biosynthesis Macrophages Molecular and cellular biology N-Formylmethionine Leucyl-Phenylalanine - pharmacology Neutrophils - drug effects Neutrophils - metabolism Recombinant Proteins - pharmacology |
title | Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A53%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukotriene%20production%20in%20human%20neutrophils%20primed%20by%20recombinant%20human%20granulocyte/macrophage%20colony-stimulating%20factor%20and%20stimulated%20with%20the%20complement%20component%20C5A%20and%20FMLP%20as%20second%20signals&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=DAHINDEN,%20C.%20A&rft.date=1988-04-01&rft.volume=167&rft.issue=4&rft.spage=1281&rft.epage=1295&rft.pages=1281-1295&rft.issn=0022-1007&rft.eissn=1540-9538&rft.coden=JEMEAV&rft_id=info:doi/10.1084/jem.167.4.1281&rft_dat=%3Cproquest_pubme%3E14928175%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14928175&rft_id=info:pmid/2833556&rfr_iscdi=true |